Practical Considerations for the Management of Cushing's Disease and COVID-19: A Case Report
Conclusion: Adrenal insufficiency might be a clinical challenge that needs a prompt treatment also in CS patients during COVID-19 infection. We should consider the possibility to titrate or temporary halt medical therapies of CS in the context of COVID-19 infection. Unexpected hyperkalemia in CS patients under treatment with heparin might be the signal of aldosterone suppression.
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research
More News: Addison's Disease | Adrenal Insufficiency | COVID-19 | Cushing's Syndrome | Diabetes | Endocrinology | Hydrocortisone | Italy Health | Lovenox | Pandemics | Pneumonia | Respiratory Medicine